TY  - GEN
AU  - Harshman,Lauren C
AU  - Li,Mingqing
AU  - Srinivas,Sandy
TI  - The combination of thalidomide and capecitabine in metastatic renal cell carcinoma -- is not the answer
SN  - 1537-453X
PY  - 2008///1107
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Capecitabine
KW  - Carcinoma, Renal Cell
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Kidney Neoplasms
KW  - Liver Neoplasms
KW  - Lung Neoplasms
KW  - Lymphatic Metastasis
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Nephrectomy
KW  - Survival Rate
KW  - Thalidomide
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/COC.0b013e318168ef47
ER  -